NCT04513509View on ClinicalTrials.gov

Rate Control in Patients With Atrial Fibrillation

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 21, 2020

Primary Completion Date

June 21, 2022

Study Completion Date

December 31, 2026

Conditions
Atrial FibrillationRate ControlCardiopulmonary Exercise Test
Interventions
DRUG

Atenolol, Bisoprolol, Metoprolol, Nebivolol, Propranolol, Diltiazem, Verapamil, digoxin

Start with empirical lower dose for 3 months, and then titrate up

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER